Accuray (ARAY) Registration filing summary

Company overview and business model

• Develops, manufactures, sells, and supports advanced radiation therapy solutions for complex and common cases, aiming to improve accuracy, flexibility, and patient outcomes.

• Key technologies include CyberKnife and TomoTherapy platforms, with applications in SRS, SBRT, IMRT, IGRT, and ART.

• Offers services such as post-contract support, installation, training, and professional services.

• Incorporated in California in 1990, reincorporated in Delaware in 2007, with principal offices in Madison, WI, and Santa Clara, CA.

Financial performance and metrics

• As of May 31, 2026, approximately 118,963,696 shares of common stock were outstanding.

• Common stock last reported at $0.29 per share on July 30, 2026, on Nasdaq Global Select Market.

Use of proceeds and capital allocation

• Will not receive proceeds from the resale of shares by selling stockholders.

• Will receive proceeds only from any cash exercise of warrants, intended for general corporate purposes.